Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mara Ardine

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
The New England Journal of Medicine|April 25, 2008
Major depressive disorderAndrea Saini, Mara Ardine, Alfredo Berruti
Acta Oncologica (Stockholm, Sweden)|March 21, 2006
Feasibility of 5-Fluorouracil resumption in a patient experiencing drug-induced acute Prinzmetal anginaVincenzo Dongiovanni, Maria Teresa Spinnler, Mara Ardine
Lung Cancer (Amsterdam, Netherlands)|July 30, 2013
Platinum rechallenge in patients with advanced NSCLC: a pooled analysisFausto Petrelli, Andrea Coinu, Mary Cabiddu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 2005
Is pathologic complete response a valid surrogate parameter of treatment efficacy in HER2 positive breast cancer patients undergoing primary chemotherapy plus trastuzamab?Alfredo Berruti, Daniele Generali, Maria Pia Brizzi, et al.
The Oncologist|November 11, 2008
Presurgical systemic treatment of nonmetastatic breast cancer: facts and open questionsAlfredo Berruti, Maria Pia Brizzi, Daniele Generali, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 10, 2007
Changes in bone mineral density after adjuvant aromatase inhibitors and fracture risk in breast cancer patientsAlfredo Berruti, Marcello Tucci, Alessandra Mosca, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 10, 2008
Could the efficacy of docetaxel in prostate cancer patients be potentiated by concomitant high-dose calcitriol administration?Alfredo Berruti, Marcello Tucci, Alessandra Mosca, et al.
Cancer Chemotherapy and Pharmacology|May 24, 2003
Gemcitabine and vinorelbine as second-line treatment in patients with metastatic breast cancer: a phase II studyMichela Donadio, Mara Ardine, Alfredo Berruti, et al.
BMC Cancer|March 19, 2013
Detection and characterization of classical and "uncommon" exon 19 Epidermal Growth Factor Receptor mutations in lung cancer by pyrosequencingLuisella Righi, Alessandra Cuccurullo, Simona Vatrano, et al.
Journal of the National Cancer Institute. Monographs|June 12, 2015
Neoadjuvant Treatment Approach: The Rosetta Stone for Breast Cancer?Daniele Generali, Mara Ardine, Carla Strina, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
The New England Journal of Medicine|April 25, 2008
Major depressive disorderAndrea Saini, Mara Ardine, Alfredo Berruti
Acta Oncologica (Stockholm, Sweden)|March 21, 2006
Feasibility of 5-Fluorouracil resumption in a patient experiencing drug-induced acute Prinzmetal anginaVincenzo Dongiovanni, Maria Teresa Spinnler, Mara Ardine
Lung Cancer (Amsterdam, Netherlands)|July 30, 2013
Platinum rechallenge in patients with advanced NSCLC: a pooled analysisFausto Petrelli, Andrea Coinu, Mary Cabiddu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 2005
Is pathologic complete response a valid surrogate parameter of treatment efficacy in HER2 positive breast cancer patients undergoing primary chemotherapy plus trastuzamab?Alfredo Berruti, Daniele Generali, Maria Pia Brizzi, et al.
The Oncologist|November 11, 2008
Presurgical systemic treatment of nonmetastatic breast cancer: facts and open questionsAlfredo Berruti, Maria Pia Brizzi, Daniele Generali, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 10, 2007
Changes in bone mineral density after adjuvant aromatase inhibitors and fracture risk in breast cancer patientsAlfredo Berruti, Marcello Tucci, Alessandra Mosca, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 10, 2008
Could the efficacy of docetaxel in prostate cancer patients be potentiated by concomitant high-dose calcitriol administration?Alfredo Berruti, Marcello Tucci, Alessandra Mosca, et al.
Cancer Chemotherapy and Pharmacology|May 24, 2003
Gemcitabine and vinorelbine as second-line treatment in patients with metastatic breast cancer: a phase II studyMichela Donadio, Mara Ardine, Alfredo Berruti, et al.
BMC Cancer|March 19, 2013
Detection and characterization of classical and "uncommon" exon 19 Epidermal Growth Factor Receptor mutations in lung cancer by pyrosequencingLuisella Righi, Alessandra Cuccurullo, Simona Vatrano, et al.
Journal of the National Cancer Institute. Monographs|June 12, 2015
Neoadjuvant Treatment Approach: The Rosetta Stone for Breast Cancer?Daniele Generali, Mara Ardine, Carla Strina, et al.
Pageof 2